Sei Investments Co. Reduces Holdings in Waters Co. (NYSE:WAT)

Sei Investments Co. reduced its stake in Waters Co. (NYSE:WAT - Free Report) by 7.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 33,320 shares of the medical instruments supplier's stock after selling 2,814 shares during the quarter. Sei Investments Co. owned approximately 0.06% of Waters worth $12,361,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Bank of Jackson Hole Trust bought a new stake in shares of Waters during the 4th quarter worth $34,000. Fortitude Family Office LLC grew its stake in shares of Waters by 235.7% during the 4th quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier's stock worth $35,000 after acquiring an additional 66 shares during the period. Steward Partners Investment Advisory LLC raised its position in shares of Waters by 129.3% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 94 shares of the medical instruments supplier's stock valued at $35,000 after purchasing an additional 53 shares during the period. EverSource Wealth Advisors LLC lifted its position in shares of Waters by 54.3% during the fourth quarter. EverSource Wealth Advisors LLC now owns 125 shares of the medical instruments supplier's stock worth $46,000 after acquiring an additional 44 shares in the last quarter. Finally, R Squared Ltd purchased a new stake in shares of Waters during the fourth quarter worth $63,000. 94.01% of the stock is owned by institutional investors.

Waters Stock Performance

NYSE:WAT traded down $13.14 during trading hours on Tuesday, reaching $355.43. The company had a trading volume of 560,995 shares, compared to its average volume of 455,183. The company has a debt-to-equity ratio of 1.14, a current ratio of 0.94 and a quick ratio of 0.65. The business's 50 day moving average price is $386.70 and its 200-day moving average price is $373.25. Waters Co. has a 1-year low of $279.24 and a 1-year high of $423.56. The firm has a market cap of $21.12 billion, a PE ratio of 33.19, a price-to-earnings-growth ratio of 3.79 and a beta of 1.00.

Remove Ads

Waters (NYSE:WAT - Get Free Report) last issued its quarterly earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $4.02 by $0.08. Waters had a return on equity of 46.31% and a net margin of 21.56%. Research analysts forecast that Waters Co. will post 12.86 EPS for the current year.

Analyst Ratings Changes

WAT has been the topic of a number of analyst reports. KeyCorp upgraded Waters from a "sector weight" rating to an "overweight" rating and set a $460.00 price objective on the stock in a research note on Monday. Barclays upgraded shares of Waters from an "underweight" rating to an "equal weight" rating and lifted their target price for the company from $360.00 to $415.00 in a research report on Monday, February 10th. UBS Group upped their price objective on Waters from $405.00 to $410.00 and gave the stock a "neutral" rating in a report on Thursday, February 13th. JPMorgan Chase & Co. increased their target price on shares of Waters from $380.00 to $390.00 and gave the company a "neutral" rating in a report on Thursday, March 6th. Finally, Robert W. Baird raised Waters from a "neutral" rating to an "outperform" rating and lifted their price target for the stock from $396.00 to $407.00 in a research note on Wednesday, March 26th. Ten research analysts have rated the stock with a hold rating, seven have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $401.31.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.